glp-1 deaths receptor agonists and risk of suicide or suicide attempts – A nationwide cohort and self-controlled case series study GLP-1RAs reduce cardiovascular deaths in

Underlying health conditions If you have any health conditions, that can also affect how quickly semaglutide works for weight loss

doi: 10.3390/nu12020444 75 ToussaintODumontPDierickJPascalTFrippiatCChainiauxFet al

Renoprotective effects of GLP-1 receptor agonists: clinical trials The first clinical evidence for beneficial effects of GLP-1 receptor agonists came from the cardiovascular outcome trials (CVOTs) that were conducted with these agents, where kidney endpoints were collected as secondary or exploratory endpoints

Because obesity and diabetes are chronic diseases, doctors typically recommend long-term maintenance rather than stopping the medication entirely